Related Experiment Video
Updated: Jun 8, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Dilated cardiomyopathy and heart failure in children
Daphne T Hsu1, Charles E Canter
1Department of Pediatrics, Albert Einstein College of Medicine, 3415 Bainbrige Avenue, Bronx, NY 10467, USA. dhsu@montefiore.org
Abstract:
This article describes the causes and outcomes of dilated cardiomyopathy in children. Genetic, infectious, metabolic, and acquired causes of dilated cardiomyopathy are discussed. The predictors for better and worse outcomes are reviewed. Guidelines for the use of medical and surgical therapies to treat heart failure in children are summarized.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
